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Abstract

USE OF SPECT DIFFERENCE IMAGING TO ASSES S SUBCORTICAL BLOOD FLOW CHANGES
DURING EPILEPTIC SEIZURES. Andrew D. Norden and Hal Blumenfeld. Departments of Neurology
and Neurobiology, Yale University School of Medicine, New Haven, CT.

Seizures are thought to arise primarily from the cerebral cortex. However, the propagation and behavioral
manifestations of seizures involve a network of both cortical and subcortical structures. The medial
thalamus and upper brainstem reticular formation are crucial areas for the maintenance of normal
consciousness. Bilateral involvement of these structures may be responsible for loss of consciousness
during partial seizures. Therefore, we sought to investigate the role of the medial thalamus and brainstem in
seizures. We performed SPECT ictal-interictal difference imaging co-registered with high-resolution MRI
scans to localize regions of cerebral blood flow changes in patients undergoing inpatient monitoring for
epilepsy. Ictal-interictal SPECT scans from 43 seizures in 40 patients were analyzed. The medial thalami
showed SPECT difference imaging changes of >20% in 18 patients. Of patients with medial thalamic
changes, the majority (13 of 18) had seizure onset in the temporal lobe, while only 1 had confirmed onset in
extratemporal structures, and the remainder were non-localized. In contrast, in the 22 patients without
>20% SPECT changes in the medial thalami, 6 had extratemporal onset, 6 had temporal onset, and the
remainder were non-localized. In patients with temporal lobe seizures, the side of greater medial thalamic
and brainstem reticular formation involvement was strongly related to SPECT injection timing such that
there was a sequential pattern of ipsilateral followed by contralateral changes. Brainstem structures showed
>20% SPECT changes in 27 of 43 seizures with no clear relation to temporal or extratemporal onset. We
conclude that the medial thalamus is preferentially involved in seizures arising from the temporal lobes,
possibly reflecting the strong connections between limbic temporal structures and the medial thalamus.
Sequential involvement of ipsilateral followed by contralateral structures in the medial thalamus and upper
brainstem may explain how seizures produce peri-ictal loss of consciousness despite incomplete
involvement of the cerebral cortex.
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Introduction
The word epilepsy comes from a Greek word that means “to be seized by forces from without.”
Interestingly, it is from this definition that the word seizure is derived as well. Apparently, early physicians
and scientists believed that patients with epilepsy were infected with dangerous supernatural beings.
Modern medical science is more comfortable with the assumption that epilepsy is caused by an organic
brain defect. Indeed, a number of epileptic syndromes are caused by discrete cerebral lesions, often the
result of developmental defects, trauma, cerebrovascular disease, tumors, tissue atrophy, or infection.
There are also some forms of epilepsy (idiopathic epilepsies), most notably those which are characterized
by absence (petit mal) seizures, for which no diseased portion of brain is currently identifiable.
Epilepsy is a disorder characterized by paroxysmal, excessive, and disorderly discharging of
neurons that generally produces clinical manifestations in the form of recurrent seizures. In some cases,
this hyperactive neuronal state can be detected by a physician with electroencephalographic (EEG)
recording. The signs and symptoms of epileptic seizures are numerous, and they often depend on the type
of seizure that one observes. Seizures are classified as partial or generalized, the former originating from a
distinct focus in the brain and the latter appearing to occur everywhere at once. Partial seizures are further
classified as simple partial (with no impairment of consciousness), complex partial (with impairment or
loss of consciousness), or partial seizures that evolve to secondarily generalized seizures. Partial seizures
are characterized by a wide variety of symptoms that may be predicted by the portion of brain from which
the seizures originate. These may include motor, sensory, autonomic, or psychological components.
Generalized seizures occur in many subtypes as well: absence (petit mal), myoclonic, tonic, atonic, clonic,
and tonic-clonic (grand mal) seizures. Each of these involves very different manifestations, so they will
not all be discussed here. However, it is worth mentioning that the initial, tonic phase of a tonic-clonic
seizure often includes increased muscle tone with a rigid, flexed posture followed by a rigid, extended
posture. During the next part of the seizure, the clonic phase, the patient experiences bilateral rhythmic
jerks of the whole body. All of this occurs in the absence of consciousness, and it is typically followed by a
confused, drowsy state or by a brief period of coma 1.
The prevalence of epilepsy is reported to be between 5 and 8 people per 1,000, or approximately
1.25 to 2 million people in the United States. Of these individuals, many have seizures that respond well to
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therapy with anti-epileptic drugs 1. However, there are between 50,000 and 300,000 people in the U.S.
whose seizures are not adequately controlled by therapy with one drug or with any comb ination of drugs 2,
3. These individuals are said to have medically intractable epilepsy. The primary treatment option
available to these patients is epilepsy surgery in which the diseased portion of brain is removed after
accurate localization of the seizure focus. As one might expect, surgery is only a possibility for epileptic
syndromes that produce partial seizures; generalized seizures do not, by definition, have a discernible
focus. Furthermore, many considerations must be taken into account by a patient who may be a candidate
for epilepsy surgery. The degree to which seizures affect a patient’s quality of life is obviously an
extremely important factor, as is the likelihood that the diseased portion of brain can be resected without
significant loss of function.
For patients who elect to have epilepsy surgery, accurate localization of the focus is absolutely
crucial to success. A localized EEG abnormality at the beginning of a seizure is typically taken to indicate
the location of the focus. However, scalp EEG recordings may be unreliable and inaccurate 4, 5. When
scalp EEG fails to localize the zone of seizure onset, depth electrodes are often implanted intracerebrally
and subdurally so that chronic recordings with minimal interference from non-neuronal tissue are possible.
Because depth electrode implantation carries with it substantial risk and expense, efforts have recently been
directed toward developing noninvasive means of precise focus identification. Such techniques include
18

F-fluorodeoxyglucose positron emission tomography (FDG-PET), which is used to measure cerebral

glucose uptake, and 99mTc-hexamethylpropyleneamineoxime (99mTc-HMPAO) single-photon emission
computed tomography (SPECT), which measures regional cerebral blood flow (rCBF). These imaging
modalities are logical choices for seizure focus localization because of the typical changes in blood flow
and metabolism that accompany seizures.
Because neurons require a continuous source of ATP for electrical signaling, and because ATP
synthesis requires a blood-delivered supply of glucose, rCBF is generally accepted as a measure of
neuronal activity in brain tissue. As epileptic seizure activity involves excessive neuronal firing, it is not
surprising that rCBF increases substantially during epileptic seizures. This finding was first reported in
1939 by Wilder Penfield and his colleagues 6. Indeed, ictal SPECT studies of patients with partial seizures
point to focal increases in CBF. Interictal SPECT scans (performed when seizures are not occurring) show
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a decrease in rCBF often in the same regions that are ictally hyperperfused 7. Parallel findings have been
demonstrated using PET, that is, ictal PET scans show areas of hypermetabolism while interictal scans
suggest hypometabolism 3, 8, 9. PET studies in humans and radiographic studies in rats also point to a
global increase in glucose metabolism in the ictal state followed by a global decrease when the seizure ends
10 . However, ictal PET studies are difficult to interpret because PET scanning has poor time resolution in
comparison to SPECT scanning. Whereas a SPECT scan reflects blood flow during a 30 – 60 second
window, the PET technique reflects metabolism during a 30 – 45 minute period. In addition, the situation
as assessed with SPECT and PET may be more complicated than these findings suggest because of the
recently detected uncoupling of metabolism and blood flow. Using a rat model of epilepsy in which
seizures are induced with intracerebral penicillin injections, Bruehl and colleagues showed significant
differences in the degree to which blood flow and glucose uptake are increased at the epileptic focus. They
also found intriguing differences between blood flow and metabolism in cortical areas close to the focus, in
remote portions of the ipsilateral cerebral hemisphere, and even in the ventrolateral and posterior thalamic
nuclei on the same side as the seizure focus. Control rats that did not receive penicillin showed close
coupling of blood flow and metabolism everywhere in the brain 11. An additional complicating factor is
that, for unknown reasons, interictal hypometabolism has been far easier to detect in humans when the
seizure focus is in the temporal lobe than when seizures commence in the frontal lobe 12.
Though the interpretation of blood flow and metabolism data is not always straightforward, PET
and SPECT have improved the ability of neurosurgeons to localize a seizure focus 13-15. Since 1995, a
team of Yale researchers headed by George Zubal and Susan Spencer has been using computer-aided
processing of SPECT images to further improve the localizing ability of SPECT scans; this work may
ultimately be extended to PET and other imaging modalities. SPECT measures blood flow by detection of
an intravenously-injected tracer substance, typically, 99mTc-HMPAO.

99m

Tc-HMPAO SPECT scanning is a

particularly versatile method because the tracer crosses the blood-brain barrier within 30 – 60 seconds after
injection, binds tightly to brain tissue, and does not redistribute for 6 – 8 hours. Thus, tracer injection
during a seizure with SPECT scanning an hour or more later allows for visualization of rCBF in the ictal
state 16. rCBF during a seizure is much more difficult to measure with PET or with other imaging
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modalities than with SPECT. Zubal and Spencer’s technique relies on computer software that co-registers
an ictal and an interictal SPECT image. The software then subtracts the two SPECT images and generates
a “difference image.”
This image highlights
areas of increased and
decreased blood flow
during a seizure, and it
also indicates the
magnitude of changes in
rCBF. The difference
image may be
superimposed onto a
high-resolution structural
Figure 1. This image represents a three-dimensional MRI reconstruction of
one patient’s brain. The SPECT difference image is super-imposed on the
MRI with red areas representing ictal hyperperfusion and blue areas ictal
hypoperfusion. As is evidenced by strong temporal lobe hyperperfusion, the
ictal SPECT scan used to prepare this image was acquired during a temporal
lobe seizure. Note that large areas of frontal, parietal, and occipital cortex
are hypoperfused at the same time.

magnetic resonance
imaging (MRI) scan of
the patient’s brain; this
allows one to determine
which brain structures are

preferentially hyper- and hypoperfused during a seizure as shown in Figure 1 3. By carefully applying this
image processing technique, one may learn a great deal about which brain structures are important in
seizure origination, propagation, and regulation.
Sometimes using techniques similar to Zubal and Spencer’s, many research groups have
conducted SPECT studies in recent years to analyze rCBF during seizures. The majority of these studies
examine rCBF in cerebral cortex because epileptic seizures have long been thought to commence in
neocortex and spread to brainstem and subcortical structures 8. As explained previously, studies of cortical
blood flow often show ictal hyperperfusion at the seizure focus with interictal hypoperfusion at the same
site. However, there is no reason to believe that the clinical manifestations of seizures depend solely on
cerebral cortex for their expression. Subcortical structures such as the basal ganglia and thalamus as well
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as the cerebellum and brainstem may be important for some aspects of seizure development or expression.
The basal ganglia are thought to play a role because of the complex motor manifestations of some seizures.
The thalamus has been implicated in seizures because of its unique electrophysiological properties and
massive connections with cerebral cortex; indeed, recent functional magnetic resonance imaging (fMRI)
studies demonstrate a close coupling of cortical and thalamic metabolism during seizures 17. The
cerebellum is an area of interest because of the increased likelihood of cerebellar atrophy in patients with
long-standing partial epilepsy (as compared to healthy individuals). This atrophy occurs for unknown
reasons, but it may well yield clues to the pathophysiology of epilepsy 18 .
Thus, in addition to cerebral cortex, scientists have used SPECT to study a number of subcortical
structures and the cerebellum. In all of these structures, ictal changes in rCBF have been observed,
although they have not always been consistent with respect to laterality or direction of change. Since more
of these studies examined cerebellum than either basal ganglia or thalamus, cerebellar blood flow will be
considered first. The most common finding of cerebellar SPECT studies is crossed cerebellar
hyperperfusion (CCH) in which the cerebellar hemisphere contralateral to the epileptic focus shows
increased blood flow during the ictal state. This has been reported in patients with various types of partial
epilepsy 18, 19, with frontal lobe epilepsy 20 , with epilepsy of the supplementary sensorimotor area
(SSMA) 21, and with partial complex seizures related to herpes simplex encephalitis 22. CCH was found
in these studies to occur in as few as 33% of patients studied 19 or in as many as 100% 21. Patients
without CCH showed ipsilateral cerebellar hyperperfusion, bilateral cerebellar hyperperfusion, or no
significant change in perfusion. Note that cerebellar hypoperfusion was never observed during seizures.
However, as one might expect, there are reports of interictal hypoperfusion of cerebellum in children with
partial epilepsy 23. This study reports that interictal hypoperfusion may be ipsilateral or contralateral to the
epileptogenic focus, and bilateral hypoperfusion was observed as well. Finally, there was one recent report
of epileptic seizures that originate in the cerebellum 24. Harvey and his colleagues at Miami Children’s
Hospital present a 6-month old female patient with a left cerebellar ganglioglioma. Using scalp and
intracranial EEG, MRI, CT, and SPECT, they confirm that this patient’s seizures, which consist of left
hemifacial contraction, head and eye deviation to the right with nystagmus, and autonomic dysfunction,
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have their origin in the diseased region of the cerebellum. After surgical removal of the tumor, this
patient’s seizures resolved completely.
Similar studies have been performed with attention paid to the basal ganglia. In their study of 8
patients with SSMA seizures, Laich et al. report that some patients showed ipsilateral hyperperfusion of the
basal ganglia, some showed bilaterally symmetric or asymmetric hyperperfusion, and one patient exhibited
no change in perfusion 21. All of these patients had significantly more blood flow to the basal ganglia than
did healthy controls. Another study demonstrates ictal hyperperfusion of the ipsilateral basal ganglia in 2
of 5 patients with complex partial seizures that originate in posterolateral cortex 25. Similar findings have
been reported in patients with temporal lobe epilepsy; one study of 42 patients with temporal lobe epilepsy
reports a statistically significant mean increase in basal ganglia perfusion of 8% during seizures 26.
Individual cases are not reported in this study, so it is unclear whether the basal ganglia changes occur
ipsilaterally, contralaterally, or bilaterally. Furthermore, the number of patients who actually show basal
ganglia hyperperfusion is not apparent. An interesting additional result, however, is that basal ganglia
perfusion in these patients correlates with upper limb dystonia such that increased asymmetry of basal
ganglia perfusion during seizures occurred more often in patients with unilateral upper limb dystonia. In
addition, the group of patients whose seizures involved unilateral dystonia showed a mean increase in basal
ganglia perfusion of 9.5%, while the group of patients who did not have dystonia showed a mean increase
of only 4.4%. Finally, interictal hypoperfusion has been shown for the basal ganglia as well. In 4 of 20
patients with medically refractory complex partial seizures, one study found basal ganglia hypoperfusion; 3
of these patients showed ipsilateral hypoperfusion, and the fourth patient showed hypoperfusion
contralaterally 27.
The third subcortical structure that has been studied in some depth using SPECT is the thalamus.
Reports concerning the thalamus are very similar to those discussed for cerebellum and basal ganglia. For
example, one of the same studies that demonstrates CCH mentions ipsilateral increases in thalamic
perfusion during seizures; unfortunately, the magnitude of increased thalamic perfusion is not mentioned,
and this result pertains only to one patient 20. One study also reports that 26% of 67 patients with temporal
lobe epilepsy show ipsilateral thalamic hypoperfusion interictally. None of these patients showed
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contralateral hypoperfusion, ipsilateral hyperperfusion, or bilateral changes in thalamic perfusion 28. Note
that these findings are in line with PET studies which show similar subcortical metabolic changes in
patients with temporal lobe epilepsy.
Clearly, a substantial amount of research effort in this field has been devoted to subcortical
structures. It is also clear that the results obtained to date are difficult to understand; though changes in
perfusion have been observed, the significance of these changes remains to be determined. Additionally,
the described changes are often reported to occur in only a small subset of patients. There has been little
speculation as to why certain patients show these changes and why many do not. There may well be
methodological issues that must be resolved before these studies will yield fruit. Also, many of these
studies use small numbers of patients because of the technical difficulty of the experiments. Patient cohorts
often comprise a wide range of ages and types of epilepsy, so the results are not as generalizable as they
might otherwise be. That being said, these studies have revealed interesting and clinically relevant
information. Though the results have not yet dramatically altered the face of epilepsy therapy, these studies
provide one of the only tools that allows physicians to examine brain activity during seizures. Accordingly,
it is surprising that there is no report in the literature of a SPECT study that examined rCBF in the
brainstem and thalamus during seizures.
The brainstem reticular formation and related structures are thought to be involved in modulating
the excitability of neurons in cerebral cortex; thus, researchers tend to think of the brainstem as a group of
structures that have a primarily regulatory role on cortical seizure activity 8. However, a small number of
animal studies during the 1980’s and early 1990’s suggest a significant role for the brainstem in
propagation and maintenance of various seizure types. For example, two independent groups of
researchers determined that seizure activity requires a functional substantia nigra. One research team
inhibited the pars reticulata of the rat substantia nigra (SNR ) with muscimol, a γ-aminobutyric acid (GABA)
agonist, and found that seizure activity was substantially inhibited. These rats were highly prone to
seizures because of “kindling,” an experimental paradigm in which electrical stimulation is repeatedly
applied to the amygdala. Initially, the electrical stimulus is insufficient to elicit a seizure, but after repeated
stimulation, the stimulus causes a seizure every time it is applied. In these rats, muscimol treatment of the
SNR bilaterally eliminated seizures in 91% of attempts that were supra-threshold for seizure induction
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before injection of the drug. Increased stimulation intensity, however, was able to elicit seizures with
regularity. Note that kindling from sites other than the amygdala is also effective in producing seizures;
muscimol treatment of the SNR blocked seizures kindled from the entorhinal cortex and olfactory structures
with similar potency. In all cases, muscimol injections were effective only when they were localized
precisely to the SNR. Surrounding structures were not equally or even similarly effective. As would be
expected, these authors report the same results when an inhibitor of GABA breakdown was injected into
the SNR and also when the SNR was bilaterally destroyed by N-methyl-D-aspartate, a neurotoxin 29.
A second group of researchers also determined that bilateral lesions of the SNR have a protective
effect against seizures 30 . In this study, seizures in rats were induced using one of two paradigms,
intravenous bicuculline (a GABA antagonist) or maximal electroshock (MES) in which the head is
electrically stimulated. They found that bilateral SNR lesions significantly attenuated seizures activity
induced by either paradigm; for seizures induced by bicuculline, higher doses of the drug were effective in
eliciting seizures after SNR lesioning, thus suggesting that SNR lesions do not eliminate the potential for
seizure generation. In MES seizures, SNR lesions blocked specifically the tonic hindlimb extension (THE)
component, a hallmark of MES seizures, thus supporting the notion that MES seizure regulatory sites are
somehow involved with the extrapyramidal motor system. These findings are analogous to the result in the
previously discussed study that increased stimulation intensities were required to produce seizures after
SNR lesions. Because previous studies demonstrated conclusively that electrical or chemical stimulation of
the SNR fails to initiate seizures, it seems most likely that the SNR is involved in amplification or
sustenance of seizure activity generated elsewhere in the brain 31 . These results are in line with an earlier
study of generalized motor seizures induced by amygdala kindling in rats which showed increased glucose
uptake bilaterally in the substantia nigra during seizures 32.
Besides the substantia nigra, the brainstem reticular formation (RF) has often been implicated as
having an important regulatory role in seizures. An important set of experiments conducted in the 1950’s
demonstrated that stimulation of the RF in the medulla, pons, or midbrain of rats and cats could induce
seizures 33. These were characterized by tonic limb extension, much like MES seizures, and there was no
evidence of hypersynchronized activity in the forebrain. Thus, it seemed that seizures, or at least the tonic
components of seizures, required participation of the brainstem RF. These seizures were unchanged in cats
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after precollicular transection, and they could not be induced by stimulation rostral to the midbrain. These
findings clearly indicated that the forebrain was not required for behavioral expression of at least one type
of seizure. Transection studies in rabbits around the same time suggested that the tonic components of
MES seizures required an intact pons 34. Again, precollicular transection failed to alter tonic seizure
components.
During the 1980’s, a series of experiments conducted by Ronald Browning and his colleagues at
South Illinois University School of Medicine verified earlier findings. First, they lesioned the superior
cerebellar peduncle (SCP) or midbrain RF in rats and attempted to induce seizures using the MES
paradigm. They found that the THE response was substantially attenuated by mechanical lesions to either
structure 35 . In a subsequent paper, they showed that these lesions had no effect on the clonic components
of seizures induced by a number of methods 36. The same group went on to show that they could eradicate
the tonic components of seizures with a smaller lesion than they had previously used. They lesioned the
nucleus reticularis pontis oralis (RPO), a part of the pontine and mesencephalic RF, along with the SCP and
were able to effectively eliminate the tonic components of sound-induced seizures in genetically epilepsyprone rats (GEPR) and MES seizures in normal rats 37. However, the clonic component of audiogenic
seizures (running and bouncing clonus) was also attenuated by the RPO/SCP lesions. This was an
interesting finding because these lesions affected the tonic components of a variety of seizure types while
sparing the clonic components (face and forelimb clonus). It quickly became clear that running and
bouncing clonus is different from face and forelimb clonus in that it depends on the brainstem and not on
the forebrain for expression. This realization occurred after rats with precollicular transections failed to
display face and forelimb clonus when exposed to electroshock or pentylenetetrazol (PTZ) seizureinduction paradigms 38. Both electroshock and PTZ-induced seizures typically contain a face and forelimb
clonic component.
Using transection experiments and multi-unit recordings in cats, a group of scientists in Mexico
during the early 1980’s sought to further define the importance of the brainstem RF in the behavioral
manifestations of seizures. This group had shown previously that PTZ-induced seizures begin in the
brainstem RF and propagate to cortex and other structures 39. However, the anatomical route by which
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seizure activity spread from RF to the spinal cord was unclear, that is, activity may have propagated via
cortex and the pyramidal tract or it may have used “extrapyramidal” pathways. By recording multi-unit
activity from the pyramidal tract while monitoring musculature with electromyography (EMG), it was
shown that there was no correlation in time between the increase of pyramidal tract activity and the onset of
clinical and EMG seizures. In contrast, the change in firing rate of RF neurons was chronologically related
to the seizure activity. Based on these results, the authors conclude that seizure activity in the RF
propagates to the spinal cord via “extrapyramidal” pathways. Note that these results do not dismiss the
pyramidal pathway as unimportant for seizure activity; rather, an increase in pyramidal tract multi-unit
firing was associated with a further increase in EMG activity, thus suggesting some kind of facilitatory role
for the cortex and pyramidal tract in PTZ-induced seizures 40 . Subsequent experiments sought to better
define the region of the RF that was most important in PTZ-induced seizure generation and concluded,
based on “pretrigeminal” transections, that the mesencephalic RF was activated first and drove other areas
41 . This finding was verified using transections within the midbrain 42 .
This view, that PTZ-induced seizures begin in the mesencephalic RF, is by no means uncontested.
Magistris et al. performed a thorough study in 1988 to characterize the roles of the forebrain, brainstem,
and spinal cord in PTZ-induced seizures 43. They studied intact cats as well as cats with precollicular
transections, spinal cord transections, or both transections. These animals were monitored with EEG and
EMG, and they received PTZ injections of various doses. In animals with precollicular transections,
cortical EEG showed seizure activity that was very similar to that observed in intact cats. However,
functional disconnection of the forebrain did inhibit the clonic motor components of these seizures. These
results bolster the argument that the forebrain is critical for clonic seizure activity and that such activity is
initiated in the forebrain. Magistris’ group therefore concludes that the mesencephalic RF is not necessary
for cortical seizure activity to occur. They point out that the multi-unit recordings of Velasco et al. are
highly filtered and may actually represent activity in pathways descending from the forebrain to the spinal
cord.
In humans, some recent compelling evidence for a key brainstem function in epileptic seizures
comes from vagus nerve stimulation therapy. One study showed that left cervical vagus nerve stimulation
could reduce the frequency of partial seizures in patients with medically refractory epilepsy by 28% 2.
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Vagus nerve stimulation directly activates neurons in brainstem nuclei that give rise to vagus nerve
efferents and receive vagal afferents. These include the dorsal motor nucleus of the vagus and the nucleus
tractus solitarius, respectively. It is not yet known why vagus nerve stimulation reduces the frequency of
epileptic seizures, but brainstem structures are quite likely to be involved.
Though the precise role of the brainstem in epilepsy remains to be clarified, then, ample evidence
suggests that the propagation and behavioral manifestations of seizures involve a network of cortical and
subcortical structures. This fact may be exploited by scientists who are interested in the neural mechanisms that
underlie consciousness. In a generalized seizure, consciousness is lost due to bilateral, diffuse involvement of
cerebral cortex with synchronized electrical activity. Partial seizures involve much smaller regions of cortex, yet
patients are often observed to have impaired consciousness during the ictus. Animal studies in 1949 showed
conclusively that the thalamus and pontomesencephalic reticular formation are crucial areas for the maintenance
of normal consciousness 44, 45. More recently, rCBF in the medial thalamus and brainstem reticular formation
has been shown to correlate with level of consciousness in healthy human volunteers 46. Furthermore, it is
known that the medial temporal structures have strong reciprocal connections with structures in the medial
thalamus such as the mediodorsal nucleus and midline thalamic nuclei 47. There are also connections
between the medial temporal lobes and brainstem. Therefore, it may be hypothesized that bilateral
involvement of the medial thalamus and pontomesencephalic reticular formation is responsible for loss of
consciousness during seizures despite only partial involvement of the cortex. Theoretically, increased
activity in the medial thalamus and brainstem reticular formation might produce widespread cortical
inhibition sufficient to cause impairment of consciousness.
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Statement of Purpose
We hope to determine, using SPECT, whether there are changes in rCBF in the medial thalamus
and brainstem reticular formation during seizures. Our goals are to fully characterize any observed changes
with respect to laterality, magnitude, and timing; to determine where these changes occur with reasonable
anatomical accuracy; and to determine whether these changes have any behavioral correlates. By
answering these questions, we hope to achieve a deeper understanding of the thalamus’ and brainstem’s
role in the pathophysiology of impaired consciousness in epilepsy. This work will shed light on the neural
substrate that underlies consciousness in general as well. Ultimately, an understanding of the mechanisms
that modulate arousal states may lead to novel therapies for epilepsy, sleep disorders, and coma.
Furthermore, the neural machinery that is responsible for the normal maintenance of consciousness may be
organized very similarly to that which controls other sophisticated human functions such as thought. If
indeed there are brainstem and thalamic structures that impact consciousness by widespread cortical
connections, it is reasonable to hypothesize that thought and memory are encoded in a similar fashion.
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Methods
Patient selection: 40 subjects with intractable seizure disorders were chosen from the cohort of patients
referred to the Yale Epilepsy Program between 1993 and 2001. Subjects were chosen for study if they had
MRI, ictal SPECT, and interictal SPECT scans of suitable quality. Though many of these subjects went on
to have intracranial electrodes placed for improved seizure localization, data obtained during the
preliminary non-invasive evaluation was used for the purposes of this study. Patients were excluded if they
had previous brain surgery or gross abnormalities of the brain. Additionally, patients whose seizures were
likely to be nonepileptic in nature were excluded.
Patient evaluation: As part of the standard pre-surgical evaluation, each patient gave a detailed history and
underwent a general and neurological examination. Diagnostic testing included a high-resolution MRI
scan, PET scan, ictal SPECT scan, interictal SPECT scan, continuous scalp EEG with audio-video
monitoring, detailed neuropsychiatric testing, and Wada testing. PET scans were obtained following the
intravenous (IV) injection of 10 mCi of 18F-FDG. Transverse image reconstruction was performed with
reoriented tomograms displayed in the axial, coronal, and saggital planes. Many patients whose seizures
remained poorly localized after this battery of non-invasive tests had intracranial depth electrodes placed
and additional in-patient monitoring. A variety of clinical information was collected for each patient,
including seizure localization,
seizure type and duration, injection
time, and surgical outcome and
pathology when applicable. Seizure
type and duration were determined
by video review of the seizure
during which the SPECT agent was
injected. All videotapes were
reviewed by the same epileptologist
along with a medical student.
Seizure duration and SPECT
injection time were determined with

Figure 2. Raw SPECT images have this appearance prior to
normalization. The scale on the right indicates magnitude of
perfusion; red areas are highly perfused, whereas blue areas
receive minimal blood flow.
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respect to the beginning and end of the electrographic and behavioral seizure. Concordance of findings on
EEG, MRI, PET, SPECT, neuropsychiatric testing, Wada testing, and surgical outcome were used to
classify seizures as temporal, extratemporal, or of uncertain onset.
Ictal-Interictal SPECT Study:

99m

Tc-HMPAO was injected for SPECT studies. As discussed earlier, this

radiopharmaceutical agent rapidly enters the brain in proportion to cerebral blood flow and becomes
trapped within cells. Cerebral uptake is more than 90% complete within 60 seconds following the IV
injection48, and since the tracer tightly binds to brain tissue, accurate scans may be obtained hours after the
seizure ends. Ictal injections of 20mCi 99mTc-HMPAO were made during seizure activity or as soon as
possible after seizure cessation. The patients were continuously monitored with video and EEG during this

Figure 3. Typical Rview layout with an MRI scan, interictal SPECT scan, ictal SPECT scan, and
SPECT difference image (from left to right). The two SPECT scans are normalized to account for
global differences in tracer uptake, and the MRI and SPECT scans are aligned in three-dimensional
space.
phase. As soon as seizure activity was witnessed, an epilepsy fellow or EEG technician quickly injected
the 99mTc-HMPAO intravenously. Interictal injections were performed in patients who were free of seizure
activity for 24 hours or more. SPECT images were typically acquired within 90 minutes after injection
using a three-headed Picker PRISM 3000 camera (Picker International, Cleveland Heights, OH).
Projection data were acquired over 40 minutes on the PRISM 3000 mounted with ultra-high-resolution,
parallel-hole collimators. A 128 x 128 matrix resolution was used with a 1.6 magnification factor.
Transverse slices were reconstructed using a routine clinical filtered back projection algorithm with Chang
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attenuation correction; the attenuation coefficient was 0.11/cm. The available reconstruction package
allows prefiltering of the projection data using a selectable Butterworth filter whose cut-off frequency can
be set to the position at which the image power spectrum is equal to the noise level in the projection
images. Approximately 30-40 transverse slices covering the whole brain were reconstructed using the
ramp filter.
Image manipulation: Rview, proprietary software designed by Colin Studholme, PhD15, was used to
analyze SPECT images (Figure 2). The software runs on a Microsoft Windows platform. For each patient,
an ictal and an interictal SPECT image were acquired as described above. A high-resolution MRI scan was
obtained as well. Both SPECT images and the MRI scan were aligned in three-dimensional space using a
sophisticated mathematical algorithm that ensured optimal alignment. The software then normalized the
two SPECT images according to total pixel counts in the brain to account for any global differences in
tracer uptake between the scans. The SPECT images were subsequently subtracted, pixel-by-pixel, to yield
a SPECT difference image, as shown in Figure 3. The difference image was then superimposed on the
MRI scan so that areas of hyper- and hypoperfusion during the ictus could be readily identified. Positive
differences represent increases in perfusion and are displayed in green, while negative differences represent
decreased perfusion and are displayed in red. The
magnitude of blood flow changes is indicated by the
intensity of the green or red color and can be measured
in Rview quite easily.
Regions of interest (ROIs): ROIs were drawn to
identify SPECT CBF changes in the thalamus and
brainstem. The anatomical locations of CBF changes
in the thalamus were based on high-resolution MRI
images using anatomical criteria defined by Potts et al
(Figure 4) 49 . The borders of the thalamus were
defined medially as the third and lateral ventricles, and
laterally as the internal capsule. The medial thalamus

Figure 4. Example anatomical boundaries
used to define the thalamus and to subdivide
the thalamus into lateral and medial regions,
based on each individual’s MRI scan.
Red=right lateral thalamus, green=right
medial thalamus, blue=left lateral thalamus,
yellow=left medial thalamus. In the top
panels, the regions are filled in with color; in
the bottom panels the same regions are
outlined with thin colored lines.

was defined as the middle third of the thalamus in the anterior to posterior axis and the medial half in the
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medial to lateral axis, running parallel to the lateral border. The medial thalamic region thus defined
includes the mediodorsal nucleus and is also likely to include the midline and intralaminar thalamic nuclei.
Similar anatomic criteria were used to define the tegmentum of the upper pons and midbrain.
Data acquisition: SPECT ictal-interictal difference images were superimposed on MRI scans for review.
Using visual inspection, one could now readily identify perfusion changes within the thalamus or brainstem
RF. Scans were systematically reviewed, and all perfusion changes within these areas were measured with
Rview and recorded. Changes of greater than 20% were accepted as significant. All scans were reviewed
by two observers who were blinded to the patients’ clinical information at the time of review, and the
locations and percent changes of all foci were indentified by consensus and recorded.
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Results

Patient

1

2

3

4

5

6

Seizure
Localization
left
hippocampus
right temporooccipital or right
anterior
temporal
right or left
temporal
neocortex
left entorhinal
cortex
left entorhinal
cortex or left
inferior
temporooccipital lesion
left temporal
neocortex

T

complex
partial (CPS)

120

(+) 30

yes

yes

T

CPS

240

(-) 180

yes

yes

T

CPS with
secondarily
generalized
tonic-clonic
seizure
(sGTCS)

94 (+55,
sGTCS )

(+) 44

yes

no

T

CPS

53

(+) 23

yes

no

T

CPS

76

(+) 45

yes

yes

74

(+) 8

yes

yes

simple
partial (SPS)
CPS,
SGTCS
CPS
CPS

95

(+) 7

yes

yes

114
168

(-) 3
(-) 149

yes
yes

no
yes

T

SPS

36

(+) 31

yes

yes

T

CPS,
SGTCS

96

(+) 40

yes

yes

T

CPS

59

(+) 14

yes

yes

T

?
CPS (with
marked left
arm tonic
extension)

?

?

yes

no

95

(+) 44

no

no

46

(+) 35

no

no

75

(+) 45

no

yes

95

(-) 23

no

no

T

right temporal

T

right temporal
right temporal
right medial
temporal lesion
left
hippocampus
left inferior
temporal
neocortex
right temporal

T
T

12
13
14

15
16
17
18
19

20

21
22
23

right entorhinal
cortex
right
hippocampus
right anterior
temporal
neocortex
right temporal
right temporal
lesion
left entorhinal
cortex
right paracentral
lobule (foot
sensorimotor
cortex)
bilateral
occipital
(right>left)
right parietal
right temporoparietal
right temporoparietal

Brainstem
reticular
formation
changes
>20%

Seizure
Type

8
9

11

Medial
thalamic
changes
>20%

Localization
Category

7

10

Injection
Time
(Relative to
seizure
end,
seconds)

Seizure
Duration
(seconds)

T

T
T
T

CPS
CPS (with
leg marching
movements)
CPS

T

SPS

34

(+) 39

no

yes

T

CPS with
crying

64

(-) 6

no

yes

ET

?

?

?

yes

yes

ET

CPS

26

(+) 11

no

no

200

(-) 150

no

no

64

(+) 69

no

yes

59

(+) 35

no

yes

ET
ET
ET

CPS,
SGTCS
CPS,
SGTCS
CPS,
SGTCS

18

25
26

parietal
right foot
sensorimotor
cortex
right foot
sensorimotor
cortex
poor localization
right hemisphere

27

poor localization

U

28

poor localization

U

poor localization
left temporooccipital
neocortex (?)
left parietooccipital (?)
left frontal (?)
poor localization
hypothalamic
hamartoma (?)

U

CPS
CPS
CPS with
bilateral
thrashing
automatisms
and grunting
CPS with
left arm
dystonia,
alert and
oriented but
amnestic
CPS

U

CPS

100

(+) 60

no

no

U

CPS, sGTCS

188

(+) 40

no

yes

U
U

CPS
tonic

35
25

(+) 15
(+) 87

no
no

no
yes

U

CPS

36

0

no

yes

94

(-) 9

no

yes

?
62
9

?
(+) 131
(+) 25

no
no
no

yes
yes
no

40

(+) 107

no

yes

244
110

(-) 146
(-) 41

no
no

no
yes

24

29
30
31
32
33

SGTCS
ET

SPS

5

(+) 20

no

yes

ET

SPS

5

(+) 19

no

no

U
U

65
95

(+) 10
(+) 10

yes
yes

no
yes

24

(+) 52

yes

yes

119

(-) 22

yes

no

70

(-) 31

no

yes

34

poor localization

U

35
36
37

poor localization
left hemisphere
left frontal (?)

U
U
U

38

left temporal (?)

U

39
40

left temporal (?)
left temporal (?)

U
U

CPS with
right-sided
clonic
movements
and tonic
rightward
head
deviation
?
CPS
SPS or CPS
CPS
w/screaming
and upper
extremity
thrashing
automatisms
CPS
CPS

Table 1. Relevant clinical information for the 40 study subjects. Localization category refers to
location of seizure onset; all seizures were categorized as arising in the temporal lobe (T),
extratemporal regions (ET), or uncertain localization (U).
Clinical features: Clinical information for each subject is presented in Table 1. 19/40 (48%) patients had
temporal lobe seizures, 5/40 (13%) had extra-temp oral seizures, and the remaining 16/40 (40%) had
uncertain seizure onset. The majority of patients (33/40; 83%) were injected for ictal SPECT scanning
during a complex partial seizure (CPS). In 7 patients, a CPS evolved into a secondarily generalized tonicclonic seizure (sGTCS). The remaining patients had simple partial seizures (SPS; 5/40; 13%), tonic
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seizures (1/40; 3%), or seizures that were difficult to classify (3/40; 8%). Seizures lasted between 5 and
244 seconds with a mean duration of 84.1±59.1 seconds. In 29/43 (67%) seizures, the injection occurred
after the end of the
electrographic seizure. Late
injections were made
between 7 and 131 seconds
after seizure cessation with a
mean delay of 39.1±29.9

INCREASE

seconds. In 11/43 (26%)
DECREASE

seizures, the injection
Figure 5. Example of a SPECT difference image super-imposed on an
MRI. This patient had left temporal lobe seizures with marked
hyperperfusion in the right medial thalamus, as seen in the coronal
section above. These images were taken from patient 5 in Table 1.
Note that the late SPECT injection (45 seconds post-ictal) is associated
with activation of the contralateral medial thalamus.

occurred prior to seizure
cessation or at the moment
the seizure ended. Injections

were made as early as 180 seconds before seizure cessation. On average, early injections took place
57.3±71.8 seconds prior to the termination of ictal activity.
SPECT findings: Previous studies at Yale have shown that the epileptogenic area can often be identified by
excess post-ictal
Temporal

14

Extra-temporal

Uncertain

13

13

Number of Patients

12
10
8
6

6

6
4
4
2

1

hypoperfusion >20% that
lasts as long as 100
Figure 6. Of the
patients with
medial thalamus
perfusion
changes of
greater than 20%,
13/18 had seizure
onset in the
temporal lobe.
Patients without
significant medial
thalamus changes
did not show the
same association.

seconds after the end of
the seizure 16. Because
it is known that changes
of at least this magnitude
are clinically important,
changes in SPECT signal

0
Patients with medial
thalamus changes
>20%

Patients without
medial thalamus
changes >20%

of more than 20% were
accepted as significant
blood flow changes.
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As shown in Table 1, medial thalamic changes of greater than 20% (and as large as 116%) were
seen unilaterally or bilaterally in 18 of 43 (42%) seizures. Pontomesencephalic reticular formation changes
of greater than 20% (and as large as 77%) were seen unilaterally or bilaterally in 27 of 43 (63%) seizures.
Interestingly, perfusion changes in thes e regions were observed to correlate with seizure localization
(Figures 5 and 6). Of patients with medial thalamus changes of more than 20%, 13 of 18 (72%) had seizure
onset in the temporal lobe. Only 1 of 18 (6%) had confirmed extra -temporal seizure onset. The remaining
4 patients had poorly localized seizures. In patients without significant medial thalamus changes, seizure
onset was more likely to occur in extra -temporal regions or to be unknown. Of the 25 seizures in which
significant medial temporal changes were absent, 6 had temporal onset, 6 extra -temporal onset, and the
remaining 13 were poorly localized (Figure 6). Thus, medial thalamic perfusion changes greater than 20%
may be strongly predictive of temporal lobe epilepsy, although not all patients with temporal lobe epilepsy
Perfusion changes in the medial thalamus
Ipsilateral
Injection prior to 30 seconds
7
post-ictal
Injection after 30 seconds post0
ictal

Contralateral
1
4

Perfusion changes in the brainstem reticular formation
Ipsilateral
Contralateral
Injection prior to 30 seconds
6
1
post-ictal
Injection after 30 seconds post1 (bilateral)
4
ictal
Table 2. Association of laterality and injection timing. In patients with temporal lobe seizures,
injection timing was strongly associated with the side of perfusion changes such that early injections
showed ipsilateral changes while later injections showed contralateral changes. This was true for
changes in the medial thalamus and brainstem reticular formation.
show these changes. The sensitivity, specificity, and positive predictive value (PPV) of these changes for
the diagnosis of temporal lobe epilepsy are 68%, 79%, and 72%, respectively.
Timing and Laterality: In patients with temporal lobe seizures, the side of greater medial thalamic
involvement was strongly related to SPECT injection timing (Table 2). Thus, 7 of 8 patients (patients 1, 2,
4, 6, 7, 8, 9, and 12) injected ictally or within 30 seconds of electrographic seizure termination showed
greater medial thalamic changes ipsilateral to the side of seizure onset. Only patient 2 had contralateral
perfusion changes. Patient 13 would have been included in this analysis as well, but the videotaped seizure
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represented by the ictal SPECT scan could not be located. In contrast, 4 of 4 patients (patients 3, 5, 10, and
11) injected more than 30 seconds after seizure termination showed greater medial thalamic changes
contralateral to the seizure focus. The midbrain and pontine reticular formation also showed a sequential
pattern of ipsilateral followed by contralateral changes (Table 2). 6 of 7 patients (patients 1, 2, 6, 7, 9, 12,
and 19) injected ictally or within 30 seconds of seizure termination had greater brainstem tegmentum
changes ipsilateral to the side of seizure onset. Again, only patient 2 had contralateral perfusion changes. 4
of 5 patients (patients 5, 10, 11, 16, and 18) injected more than 30 seconds after seizure termination had
greater brainstem tegmentum changes contralateral to the side of seizure onset. Only patient 11 showed
bilateral changes. Thus, sequential activation of ipsilateral followed by contralateral thalamus and
brainstem reticular formation was observed in the vast majority of patients. This phenomenon may reflect
the pathophysiology of impaired consciousness during partial seizures.
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Discussion
Though epilepsy has long been considered a disorder of cerebral cortical dysfunction, a variety of
animal and human studies have demonstrated the importance of thalamic and brainstem structures in
seizures. The recent success of vagus nerve stimulation in controlling seizures and even preventing them
after an aura has begun is particularly strong evidence in support of a role for these subcortical structures 2.
Some of these regions, particularly medial thalamus and pontomesencephalic reticular formation, are also
known to play a role in regulation of consciousness. Early studies demonstrate that destruction of these
areas render cats somnolent and inhibit low-voltage fast EEG activity typically seen in the waking state 45,
50 . Furthermore, blood flow changes in these areas in humans correlate with level of consciousness 46.
Because of the extensive connections known to exist between these structures and cortex, an interesting
hypothesis suggests that medial thalamus and brainstem reticular formation are important for changes in
consciousness during epileptic seizures. Since much of cortex is spared of electrical involvement during
partial seizures, it is difficult to account for the impairment of consciousness that often occurs. If, however,
deep brainstem and thalamic structures are electrically activated during seizures, they may depress cortical
activity through their widespread anatomical connections and thereby affect consciousness as one typically
observes during generalized seizures.
To investigate this hypothesis, we utilized SPECT ictal-interictal difference imaging in 40 patients
with intractable epilepsy. We demonstrated that 42% and 63% of the 43 seizures analyzed exhibited
perfusion changes in the medial thalamus and pontomesencephalic reticular formation, respectively.
Interestingly, of the patients with significant medial thalamus changes, 72% had temporal lobe seizure
onset, whereas only 24% of patients without these changes had temporal lobe onset. Finally, we showed
that SPECT injection timing was strongly associated with laterality of changes in the medial thalamus.
Seizures with true ictal or early post-ictal injections were much more likely to show medial thalamus
involvement ipsilateral to the seizure focus. Late injections, however, were much more likely to show
contralateral involvement.
A number of conclusions may be drawn from this data. First, focal perfusion changes in thalamic
and brainstem regions support involvement of these structures in human epilepsy. Additionally, the
preferential involvement of medial thalamus in temporal lobe seizures likely reflects the strong connections
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between limbic temporal structures and medial thalamus. Finally, sequential involvement of ipsilateral
followed by contralateral structures in the medial thalamus and upper brainstem may explain how seizures
produce peri-ictal loss of consciousness despite incomplete involvement of the cerebral cortex.
Several important questions pertaining to each of these conclusions remain to be answered by
future investigations. Though this data supports involvement of thalamic and brainstem structures in
epilepsy, significant perfusion changes in these regions were not observed in every patient. Rather, medial
thalamus changes were observed in 42% of patients, and brainstem reticular formation changes occurred in
63%. It is likely that these low numbers result from the heterogeneity of this patient group. Because a
variety of seizure types are represented and because there are relatively few patients with each of these
seizure types, one may fail to notice an important trend that occurs in one subset of patients. This explains
why it was critical to conduct a subgroup analysis in which changes in the medial thalamus and brainstem
were examined based on seizure localization. Indeed, when patients with significant medial thalamus
changes were analyzed separately, it became clear that the majority of them (72%) had temporal lobe
seizure onset. This leaves 28% of patients with significant medial thalamus changes and extra-temporal or
unknown seizure onset. The mechanism by which medial thalamus becomes activated in these patients is
unclear, and the impact this activation has on consciousness is not known.
The finding of sequential involvement of ipsilateral followed by contralateral thalamus and
brainstem activation is unexpected and intriguing. There is no published data to suggest that the two sides
of the thalamus or brainstem have unique functions with respect to seizure propagation or loss of
consciousness. Of course, it is logical to assume that the side ipsilateral to the seizure focus would become
involved first. This side is physically closest to the seizure focus and has the strongest anatomical
connectivity. However, it is not clear why the ipsilateral side returns to normal levels of perfusion when
the contralateral side becomes activated. Furthermore, the path of propagation of electrical activation from
one side of the thalamus or brainstem to the other is unknown.
Ideally, in future studies one would have a large cohort of patients with proven temporal lobe
epilepsy and an equally large cohort of patients with extra -temporal epilepsy. To be certain that the seizure
localization is correct, one should select patients who have undergone epilepsy surgery and achieved
excellent results, that is, the patients should be free of seizures after the operation. In the current study, it is
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difficult to generalize the results because of the relatively small number of patients and also because a wide
variety of epilepsy and seizure subtypes are represented. By creating “pure” patient groups, one could
better understand in which patients thalamic and brainstem perfusion changes are important. In addition, it
would be helpful to choose patients with both simple and complex partial seizures. Considering that a chief
aim of this study was to evaluate the role of thalamic and brainstem structures in consciousness, one should
directly compare seizures in which consciousness is maintained with seizures in which consciousness is
impaired or lost. There were too few patients with simple partial seizures in our study to draw definitive
conclusions. In an ideal study, one could use rigorous statistical techniques to compare groups of patients
with surgery-proven temporal lobe epilepsy and simple partial or complex partial seizures only. There is a
statistical software package, Statistical Parametric Mapping (SPM), that allows users to average SPECT
scans across several patients and then analyze these averaged scans to assess statistical significance of
group differences. However, such a system requires that each patient’s MRI be modified so as to be superimposed on a standard reference MRI. It also requires that each group of patients be as homogeneous as
possible. Because of time constraints, the SPM system was not a viable option for data analysis in this
study.
This study has one additional shortcoming that must be mentioned. Because the measurement of
perfusion relies on SPECT imaging, the anatomical resolution is limited. Typical SPECT scanning used in
clinical situations allows one to discriminate between points that are approximately 7 mm apart 51 .
Therefore, although it is realistic to determine that changes occur in the medial thalamus or in the brainstem
reticular formation, it would not be scientifically sound to assess changes in small subdivisions of these
regions. Although we believe, for example, that the mediodorsal and intralaminar nuclei are included in
ROIs around the medial thalamus, the medial thalamus measures approximately 1 cm in diameter, so it is
impossible to determine which of these substructures are responsible for the measured perfusion changes.
However, SPECT remains an extremely powerful imaging technique for this type of study because it is the
only modality that allows for routine measurement of ictal blood flow. Only under rare circumstances can
one capture an ictal image with PET or fMRI scanning.
Though important questions remain to be answered, this study sheds light on the impact of
thalamus and brainstem structures on consciousness in epileptic patients. Future studies will determine
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which seizure types preferentially activate these structures and how electrical activity propagates to them.
As the anatomic resolution of SPECT and other imaging techniques improve, researchers will be able to
examine subcortical structures more closely and perhaps identify critical subregions of thalamus and
reticular formation that are important in maintenance of consciousness. Perhaps most exciting, functional
studies of this sort may ultimately reveal the true neural substrate of consciousness. With this information
in hand, neurologists will be in a position to better understand disorders of consciousness such as epilepsy,
sleep disorders, and coma.
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